| GCTK Stock | | | USD 0.36 1.21 77.07% |
This module uses fundamental data of GlucoTrack to approximate its Piotroski F score. GlucoTrack F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of GlucoTrack. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about GlucoTrack financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
GlucoTrack Altman Z Score,
GlucoTrack Correlation,
GlucoTrack Valuation, as well as analyze
GlucoTrack Alpha and Beta and
GlucoTrack Hype Analysis.
For more information on how to buy GlucoTrack Stock please use our
How to buy in GlucoTrack Stock guide.
At this time, GlucoTrack's
Short and Long Term Debt Total is quite stable compared to the past year.
Long Term Debt is expected to rise to about 212
K this year, although the value of
Net Debt To EBITDA will most likely fall to 0.52. At this time, GlucoTrack's
EV To Sales is quite stable compared to the past year.
Inventory Turnover is expected to rise to 0.32 this year, although the value of
Free Cash Flow Yield is projected to rise to
(1.15).
At this time, it appears that GlucoTrack's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Higher Leverage| Focus | |
| Change In Outstending Shares | |
GlucoTrack Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to GlucoTrack is to make sure GlucoTrack is not a subject of accounting manipulations and runs a healthy internal audit department. So, if GlucoTrack's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if GlucoTrack's financial numbers are properly reported.
GlucoTrack F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between GlucoTrack's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards GlucoTrack in a much-optimized way.
Click cells to compare fundamentals
About GlucoTrack Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
About GlucoTrack Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GlucoTrack's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlucoTrack using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of GlucoTrack based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectWhen determining whether GlucoTrack is a good investment, qualitative aspects like company
management, corporate governance, and ethical practices play a significant role. A
comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock.
Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock: Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets | Return On Equity |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine
if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.